Sulphanilamide in the treatment of pulmonary tuberculosis with special reference to its action on the blood sedimentation rate
dc.contributor.author
Salzmann, Kenneth Douglas
en
dc.date.accessioned
2019-02-15T14:19:54Z
dc.date.available
2019-02-15T14:19:54Z
dc.date.issued
1940
dc.description.abstract
en
dc.description.abstract
(1) The present investigation was stimulated by the
absence of any publication concerning the use of sulphanilamide
in pulmonary tuberculosis.
(2) The pathology of tuberculosis is reviewed briefly
including a description of the tubercle bacillus and
the process taking place in the lung after infection
by the bacillus.
(3) The avascular nature of the tubercle is a bar to
successful chemotherapy, and for the same reason
fibroid lesions are resistant.
(4) Adequate contact between the focus and remedial
agent can only be achieved by means of hyperaemic lung
tissue: such conditions are fulfilled .best by rapidly
spreading exudative lesions with or without cavitation
(5) When there is rapid tissue destruction there is
almost certainly mixed infection and this contributes
to systemic disturbance.
(6) Acute forms of Tuberculosis, particularly if bilateral,
are the most lethal and least responsive to
treatment.
(7) The composition of sulphanilamide and allied drugs,
their favourable action on various micro-organisms, including,
an incomplete bacteriostatic action on the tubercle
bacillus are described: their toxic effects, influence
n the blood and mode of action are discussed.
(8) Present, day treatment of tuberculosis is reviewed.
The results obtained are recorded and mention is made
of the possibility of combining each method with sulpanilamide.
Collapse Therapy is relatively ineffective
in bilateral disease, gold of doubtful use and
often too toxic, and tuberculin is both useless and
dangerous if there is much systemic upset.
(9) The eighteen cases to whom rubiazol was given are
described, and the effect of the drug is estimated by
reference to its action on the temperature, pulse,
weight, sputum, sedimentation rate etc.
(10) Toxic effects were minimal - transient cyanosis and a
scarlatiniform rash - both disappearing without
stoping treatment. Rubiazol is probably the safest form
of sulphanilamide for use over a prolonged period, but
frequent examinations of the blood are essential to
avoid possible agranulocytosis.
(11) Certain blood changes occurred and it is suggested
that these may have resulted indirectly from action of
rubiazol on the tubercle bacillus itself.
(12) The sedimentation rate is not a very precise
measure of, improvement. Profound alterations in the
rate follow the use of gold and rubiazol together.
(13) It is suggested that trial of gold and sulphanliamide
should be made in treatment of rheumatoid arthritis.
(14) The action of sulphanilamide in tuberculosis is
mainly on the secondary infecting organisms - especially
the streptococci.
(15) Presence in the sputum of streptococci or other organisms
than the tubercle bacillus is not, per se, an indication
for use of sulphanilamide. There must be
evidence of their activity..
(16) Indications for sulphanilamide are rapidly
spreading exudative tuberculosis, with or without
cavities, a pulse-rate in excess of 95, temperature
100°F or more, copious sputum containing streptococci
etc., numerous moist ráles and a rapid sedimentation
rate.
(17) Speedy improvement in recent tuberculous pleural
effusion suggests a possible use for sulphanilamide in
this condition, and other early lesions which evoke
pyrexia and tachycardia.
(18) Sulphanilamide is useless in chronic and indolent
forms of tuberculosis unassociated with systemic disturbance.
- - - - -
Eighteen cases of pleuro-pulmonary tuberculosis
were treated with rubiazol a compound closely similar
to sulphanilamide. Some of the cases seemed to derive
benefit. It is suggested that sulphanilamide is of
most use in active lesions with mixed infection. The
drug may be of special service in patients for whom
collapse therapy, gold and other forms of treatment cannot
be used.
en
dc.identifier.uri
http://hdl.handle.net/1842/33810
dc.publisher
The University of Edinburgh
en
dc.relation.ispartof
Annexe Thesis Digitisation Project 2019 Block 22
en
dc.relation.isreferencedby
en
dc.title
Sulphanilamide in the treatment of pulmonary tuberculosis with special reference to its action on the blood sedimentation rate
en
dc.type
Thesis or Dissertation
en
dc.type.qualificationlevel
Doctoral
en
dc.type.qualificationname
MD Doctor of Medicine
en
Files
Original bundle
1 - 1 of 1
- Name:
- SalzmannKD_1940redux.pdf
- Size:
- 32.03 MB
- Format:
- Adobe Portable Document Format
This item appears in the following Collection(s)

